China Health Group Inc

Price Chart

Risk-Adjusted Performance

China Health Group Inc (8225) Price Performance

China Health Group Inc (8225) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at HKD0.14.

Over the past year, 8225 has traded between a low of HKD0.13 and a high of HKD0.20. The stock has lost 8.1% over this period. It is currently 30.3% below its 52-week high.

China Health Group Inc has a market capitalization of $135.37M, with a price-to-earnings ratio of 6.80.

About China Health Group Inc

China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People's Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.

Compare China Health Group Inc

Side-by-side comparison against top Healthcare peers.